Optimal sequencing of anti-HER2 therapy throughout the continuum of HER2-positive breast cancer: evidence and clinical considerations.
about
Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective.Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS geneIn vivo near-infrared imaging of ErbB2 expressing breast tumors with dual-axes confocal endomicroscopy using a targeted peptide.
P2860
Optimal sequencing of anti-HER2 therapy throughout the continuum of HER2-positive breast cancer: evidence and clinical considerations.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Optimal sequencing of anti-HER ...... e and clinical considerations.
@en
type
label
Optimal sequencing of anti-HER ...... e and clinical considerations.
@en
prefLabel
Optimal sequencing of anti-HER ...... e and clinical considerations.
@en
P2860
P1433
P1476
Optimal sequencing of anti-HER ...... e and clinical considerations.
@en
P2093
Rachel Wuerstlein
P2860
P2888
P304
P356
10.1007/S40265-013-0118-Z
P577
2013-10-01T00:00:00Z
P6179
1043768392